AKT1 and lung cancer: Finally, the molecular consequences derived from combining metformin and sotorasib remain unexplored; therefore, this study aimed to analyze their effects on cell viability, apoptosis and the activity of MAPK and AKT-mTOR pathways in lung cancer cell lines harboring different KRAS mutational statuses.